Off note, these four SLE patients and two control patients who tested borderline in the ELiA dsDNA (and were consecutively excluded from specificity and sensitivity calculations for this assay) tested abnormal or normal in the Anti-dsDNA-NcX ELISA exactly 50% of the time in each group. The gene discussed is TLX2; the disease is systemic lupus erythematosus.